journal article·2018

Hypoxia activates enhanced invasive potential and endogenous hyaluronic acid production by glioblastoma cells

Jee-Wei Emily Chen, Jan Lumibao, Audrey Blazek, H. Rex Gaskins, Brendan Harley

Biomaterials Science· Volume 6· Issue 4
Publisher page

Abstract

Glioblastoma (GBM) is the most common, aggressive, and deadly form of adult brain cancer, and is associated with a short survival rate (median 12-15 months, 5+ year less than 5%). The complex tumor microenvironment includes matrix transitions at the tumor margin, such as gradations in hyaluronic acid (HA). In addition, metabolic stress induced by decreased oxygen content across the tumor may contribute to tumor progression. However, cross-talk between matrix composition and metabolic stress remains unclear. In this study, we fabricated an in vitro brain memetic HA-decorated gelatin hydrogel platform incorporating variable oxygen concentrations to mimic intra-tumoral hypoxia. We observed that EGFR status (wildtype vs. a constitutively active EGFRvIII mutant) of U87 GBM cells affected proliferation and metabolic activity in response to hypoxia and matrix-bound HA. The use of an invasion assay revealed that invasion was significantly enhanced in both cell types under hypoxia. Moreover, we observed compensatory secretion of soluble HA in cases of enhanced GBM cell invasion, consistent with our previous findings using other GBM cell lines. Interestingly, U87 GBM cells adapted to hypoxia by shifting toward a more anaerobic metabolic state, a mechanism that may contribute to GBM cell invasion. Collectively, these data demonstrate that the use of a three-dimensional hydrogel provides a robust method to study the impact of matrix composition and metabolic challenges on GBM cell invasion, a key factor contributing to the most common, aggressive, and deadly form of adult brain cancer.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Cancer, Hypoxia, and Metabolism · Proteoglycans and glycosaminoglycans research · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Dept. of Chemical and Biomolecular Engineering

University of Illinois at Urbana-Champaign

Urbana

USA

Carl R. Woese Institute for Genomic Biology

Division of Nutritional Sciences

Dept. of Bioengineering

Funding

National Cancer Institute · National Institute of Biomedical Imaging and Bioengineering · University of Illinois at Urbana-Champaign

References (66)

Show source-provided references
1. Stupp · N. Engl. J. Med. · 2005 · 352 · 98710.1056/NEJMoa043330 ↗
2. Furnari · Genes Dev. · 2007 · 21 · 268310.1101/gad.1596707 ↗
3. Wen · N. Engl. J. Med. · 2008 · 359 · 49210.1056/NEJMra0708126 ↗
4. Nakada · Cell. Mol. Life Sci. · 2007 · 64 · 45810.1007/s00018-007-6342-5 ↗
5. Ehsan · Integr. Biol. · 2014 · 6 · 60310.1039/c3ib40170g ↗
6. Poste · Nature · 1980 · 283 · 13910.1038/283139a0 ↗
7. Mourad · Surg. Neurol. · 2005 · 63 · 51110.1016/j.surneu.2004.08.062 ↗
8. Watkins · Nat. Commun. · 2014 · 5 · 419610.1038/ncomms5196 ↗
9. de Groot · Neuro-Oncology · 2010 · 12 · 23310.1093/neuonc/nop027 ↗
10. Clavreul · J. Pathol. · 2014 · 233 · 7410.1002/path.4332 ↗
11. Wallner · Int. J. Radiat. Oncol., Biol., Phys. · 1989 · 16 · 140510.1016/0360-3016(89)90941-3 ↗
12. Delgado-López · Clin. Transl. Oncol. · 2016 · 18 · 106210.1007/s12094-016-1497-x ↗
13. M. R. Wiranowska and M. V.Rojiani , Extracellular Matrix Microenvironment in Glioma Progression , InTech , 2011
14. E. Syková , in The Neuronal Environment: Brain Homeostasis in Health and Disease , ed. W. Walz , Humana Press , Totowa, NJ , 2002 , pp. 57–81 , 10.1007/978-1-59259-108-4_310.1007/978-1-59259-108-4_3 ↗
15. Quirico-Santos · Arq. Neuro-Psiquiatr. · 2010 · 68 · 79910.1590/S0004-282X2010000500024 ↗
16. Misra · FEBS J. · 2011 · 278 · 142910.1111/j.1742-4658.2011.08071.x ↗
17. Toole · Nat. Rev. Cancer · 2004 · 4 · 52810.1038/nrc1391 ↗
18. Monslow · Front. Immunol. · 2015 · 6 · 23110.3389/fimmu.2015.00231 ↗
19. Lam · Acta Biomater. · 2014 · 10 · 157110.1016/j.actbio.2013.07.025 ↗
20. Hulkower · Pharmaceutics · 2011 · 3 · 10710.3390/pharmaceutics3010107 ↗
21. Y. Kim and S.Kumar , in Tumors of the Central Nervous System, Volume 13: Types of Tumors, Diagnosis, Ultrasonography, Surgery, Brain Metastasis, and General CNS Diseases , ed. M. A. Hayat , Springer , Netherlands, Dordrecht , 2014 , pp. 253 – 266 , 10.1007/978-94-007-7602-9_2610.1007/978-94-007-7602-9_26 ↗
22. Umesh · PLoS One · 2014 · 9 · e10177110.1371/journal.pone.0101771 ↗
23. Ananthanarayanan · Biomaterials · 2011 · 32 · 791310.1016/j.biomaterials.2011.07.005 ↗
24. Heffernan · Ann. Biomed. Eng. · 2015 · 43 · 196510.1007/s10439-014-1223-1 ↗
25. Chen · Macromol. Biosci. · 2017 · 17 · 170001810.1002/mabi.201700018 ↗
26. Vartanian · Neuro Oncology · 2014 · 16 · 116710.1093/neuonc/nou035 ↗
27. Rong · J. Neuropathol. Exp. Neurol. · 2006 · 65 · 52910.1097/00005072-200606000-00001 ↗
28. Carreau · J. Cell. Mol. Med. · 2011 · 15 · 123910.1111/j.1582-4934.2011.01258.x ↗
29. Vaupel · Antioxid. Redox Signaling · 2007 · 9 · 122110.1089/ars.2007.1628 ↗
30. Rajendran · Clin. Cancer Res. · 2004 · 10 · 224510.1158/1078-0432.CCR-0688-3 ↗
31. Brat · Cancer Res. · 2004 · 64 · 92010.1158/0008-5472.CAN-03-2073 ↗
32. Kaur · Neuro-Oncology · 2005 · 7 · 13410.1215/S1152851704001115 ↗
33. Hardee · Am. J. Pathol. · 2012 · 181 · 112610.1016/j.ajpath.2012.06.030 ↗
34. Theys · Radiother. Oncol. · 2009 · 92 · 39910.1016/j.radonc.2009.06.017 ↗
35. Vivanco · Cancer Discovery · 2012 · 2 · 45810.1158/2159-8290.CD-11-0284 ↗
36. Liu · Oncotarget · 2016 · 7 · 468010.18632/oncotarget.6730 ↗
37. Mao · Cancer Invest. · 2012 · 30 · 4810.3109/07357907.2011.630050 ↗
38. Franovic · Proc. Natl. Acad. Sci. U. S. A. · 2007 · 104 · 1309210.1073/pnas.0702387104 ↗
39. Heimberger · J. Transl. Med. · 2005 · 3 · 3810.1186/1479-5876-3-38 ↗
40. Pedron · Adv. Mater. · 2015 · 27 · 156710.1002/adma.201404896 ↗
41. Pedron · J. Biomed. Mater. Res., Part A · 2013 · 101 · 340510.1002/jbm.a.34637 ↗
42. Pedron · Biomaterials · 2013 · 34 · 740810.1016/j.biomaterials.2013.06.024 ↗
43. Mahadik · Biomaterials · 2015 · 67 · 29710.1016/j.biomaterials.2015.07.042 ↗
44. Pedron · Adv. Mater. · 2015 · 27 · 156710.1002/adma.201404896 ↗
45. Pence · Biotechnol. Bioeng. · 2015 · 112 · 218510.1002/bit.25622 ↗
46. Caliari · Biomaterials · 2011 · 32 · 533010.1016/j.biomaterials.2011.04.021 ↗
47. Pedron · Biomaterials · 2013 · 34 · 740810.1016/j.biomaterials.2013.06.024 ↗
48. Caliari · Adv. Healthcare Mater. · 2015 · 4 · 83110.1002/adhm.201400809 ↗
49. Schwartz · bioRxiv · 201710.1101/164525 ↗
50. Kalkan · Crit. Rev. Eukaryotic Gene Expression · 2015 · 25 · 36310.1615/CritRevEukaryotGeneExpr.2015015601 ↗
51. Minet · FEBS Lett. · 2000 · 468 · 5310.1016/S0014-5793(00)01181-9 ↗
52. Koh · Trends Biochem. Sci. · 2012 · 37 · 36410.1016/j.tibs.2012.06.004 ↗
53. Guo · PLoS One · 2013 · 8 · e7207910.1371/journal.pone.0072079 ↗
54. Xu · J. Biol. Chem. · 2002 · 277 · 1136810.1074/jbc.M108347200 ↗
55. Giese · Int. J. Cancer · 1996 · 67 · 27510.1002/(SICI)1097-0215(19960717)67:2<275::AID-IJC20>3.0.CO;2-9 ↗
56. Hatzikirou · Math. Med. Biol. · 2012 · 29 · 4910.1093/imammb/dqq011 ↗
57. Kim · BMC Cancer · 2009 · 9 · 2710.1186/1471-2407-9-27 ↗
58. Wang · Biochem. Biophys. Res. Commun. · 1995 · 216 · 66910.1006/bbrc.1995.2674 ↗
59. Zhong · Cancer Res. · 1999 · 59 · 5830
60. Shweiki · Proc. Natl. Acad. Sci. U. S. A. · 1995 · 92 · 76810.1073/pnas.92.3.768 ↗
61. Zagzag · Lab. Invest. · 2006 · 86 · 122110.1038/labinvest.3700482 ↗
62. Du · Neuro-Oncology · 2008 · 10 · 25410.1215/15228517-2008-001 ↗
63. Wolf · J. Cell Biol. · 2003 · 160 · 26710.1083/jcb.200209006 ↗
64. Lu · Lab. Invest. · 2003 · 84 · 810.1038/labinvest.3700003 ↗
65. Kim · Mol. Cancer Res. · 2014 · 12 · 141610.1158/1541-7786.MCR-13-0629 ↗
66. Stern · Exp. Cell Res. · 2002 · 276 · 2410.1006/excr.2002.5508 ↗